Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Core One Labs Inc C.COOL

Alternate Symbol(s):  CLABF

Core One Labs Inc. is a Canada-based life sciences biotechnology research and development company. The Company is focused on bringing psychedelic medicines to market through the development and production of psychedelic compounds, the advancement of psychedelic assisted treatments, and the integration of delivery systems technology. Its subsidiary, Vocan Biotechnologies Inc., has developed and filed for patent protection of a proprietary psilocybin production system using engineered bacteria. It is also the holder of four provisional patents for the development of psychedelic-based pharmaceutical formulations targeting neurological and mental health disorders, under its subsidiary Akome Biotech Ltd., and three provisional patents under its other subsidiary, Awakened Biosciences Inc., for additional synthetic technologies for psilocybin and psilocin production methods. It also holds an interest in four medical clinics, which maintain a combined database of more than 275,000 patients.


CSE:COOL - Post by User

Bullboard Posts
Post by Straniuson Jul 10, 2017 1:32pm
221 Views
Post# 26451637

Further Change to Timeline Guidance

Further Change to Timeline GuidanceHere is an update to my May 15 post (here).

With the June monthly report, the company has further delayed the timing on the completion of the construction on the Adelanto facility (and with that presumably the commencement of operations). It would be really nice for the company to provide an update to shareholders on what is causing additional delays at this juncture.

Are the delay causing issues ones for which a solution is known and being implemented or are they issues where no solution is currently known (in which case we should expect a much much LONGER delay)?

Here is the summary in table form:

https://investorshub.advfn.com/uimage/uploads/2017/7/10/ilyrt2017-07-10_LDS_Guidance.jpeg

User image

The source of the above data has been pulled from the sources listed below:


May 4 Press Release (link)
 
Construction of the Adelanto Facility is currently underway.  LDS expects that construction of the extraction and manufacturing wing of the joint use Adelanto Facility will be completed in May 2017, with construction of the nursery and marijuana cultivation wing of the Adelanto Facility expected to be completed in July 2017.
 
May 15 Press Release (link)
 
Separately but related, LDS expects that construction of the extraction and manufacturing wing of the joint use Adelanto Facility will be completed in late June 2017, with extraction related operations expected to commence in July 2017.  It is anticipated that the construction of the cannabis cultivation wing of the Adelanto Facility will be completed in July 2017, with cultivation related operations expected to commence in September 2017.
 
 
July 10 – June Monthly Report (link)
 
During the month of June, Lifestyle Delivery Systems Inc. continued its work on construction of the permitted facility in Adelanto, California. The Issuer expects that construction of the extraction and manufacturing wing of the Adelanto Facility will be completed in July 2017, with construction of the nursery and marijuana cultivation wing to be completed in August 2017.


~S
Bullboard Posts